The predictive value of endothelial activation and stress index (EASIX) for major adverse cardiovascular events in patients with coronary slow-flow phenomenon: a retrospective cohort study

Inside the heart's vast network of blood vessels, there exists a subtle but dangerous malfunction known as the coronary slow flow phenomenon. Imagine a highway where the road is perfectly clear, with no accidents, construction, or blockages to stop traffic, yet the cars move with frustratingly sluggish speed. In the human body, this happens when the large arteries feeding the heart muscle appear normal on an X-ray, but the blood takes an unusually long time to travel through the tiny, microscopic vessels at the end of the line. For years, doctors viewed this condition as a harmless curiosity, a strange quirk of anatomy that required no treatment. However, modern medicine has begun to realize that this sluggish flow is often a warning sign. It suggests that the inner lining of the blood vessels is damaged and inflamed, a state that can eventually lead to heart attacks, strokes, or sudden death. The challenge for physicians has been finding a way to tell which patients with this slow flow are merely experiencing a minor inconvenience and which ones are walking a dangerous path toward a major cardiac event.

A team of researchers at Kocaeli University in Turkey set out to solve this puzzle by looking for a specific signal in the blood that could predict future trouble. They focused on a calculation called the Endothelial Activation and Stress Index, or EASIX. This is not a complex machine or a new drug, but rather a simple score derived from three routine blood tests that almost every hospital performs: a measure of how well the kidneys are filtering waste, the count of platelets that help blood clot, and a level of an enzyme called lactate dehydrogenase that rises when cells are under stress or damaged. The researchers reasoned that if the blood vessels are indeed inflamed and stressed, these three numbers would shift in a predictable way. To test this, they gathered data from 517 patients who had been diagnosed with the slow flow phenomenon. These individuals had undergone heart catheterization, a procedure where a thin tube is threaded into the heart to take pictures of the arteries, confirming that their vessels were open but their blood flow was delayed. The team then followed these patients for a median of 27 months, tracking who remained healthy and who suffered a major adverse cardiovascular event, a term the doctors use to describe a heart attack, a stroke, or death from any cause.

The results of this long-term observation were striking and provided a clear distinction between low-risk and high-risk patients. When the researchers divided the group based on their EASIX scores, a sharp divide emerged. Among the patients with lower scores, indicating less cellular stress and healthier blood vessels, only 4 percent experienced a major cardiac event during the follow-up period. In stark contrast, among the patients with higher scores, the rate of heart attacks, strokes, and deaths jumped to 23 percent. This difference was not a fluke; the data showed that a high score was a powerful predictor of danger, even after the researchers accounted for other known risk factors like age, diabetes, smoking, and kidney function. The study found that patients with the higher scores were nearly three times more likely to suffer a major event than those with lower scores. Furthermore, the researchers discovered that this blood test score was not just a marker of general poor health; it actually tracked with the severity of the slow flow itself. Patients with the highest scores tended to have the most delayed blood flow and the most widespread involvement of the heart's vessels, suggesting that the test was measuring the true intensity of the underlying disease.

The study also looked at whether the speed of the blood flow itself, measured by counting the number of video frames it took for dye to travel through the arteries, could predict who would get sick. Surprisingly, the speed of the flow and the number of vessels involved did not reliably predict future heart attacks or strokes on their own. It was the biological stress reflected in the blood that mattered most. The researchers calculated that the EASIX score could correctly identify patients who would remain event-free with a high degree of accuracy, acting as a reliable filter to separate the safe from the unsafe. While the study was limited to a single hospital and looked back at past records rather than following patients forward in a new experiment, the consistency of the findings offers a compelling new tool. It suggests that a simple, inexpensive blood test could help doctors identify the small subset of patients with slow blood flow who are actually at high risk, allowing for closer monitoring and more aggressive care, while sparing the majority of patients from unnecessary worry. The work does not claim to have cured the condition or to be a perfect crystal ball, but it does provide a clear, evidence-based way to look into the future of these patients and understand the hidden danger within their slow-flowing veins.